These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6775329)
21. Antagonism by naloxone of morphine-induced single-dose dependence and antinociception in mice. Smits SE Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):689-96. PubMed ID: 12548 [TBL] [Abstract][Full Text] [Related]
22. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Jensen TS; Yaksh TL Brain Res; 1986 Jan; 363(1):99-113. PubMed ID: 3004644 [TBL] [Abstract][Full Text] [Related]
23. Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat. Sharpe LG; Garnett JE; Cicero TJ Behav Biol; 1974 Jul; 11(3):303-13. PubMed ID: 4411999 [No Abstract] [Full Text] [Related]
24. Hyperglycaemia, a morphine-like effect produced by naloxone in the cat. Feldberg W; Pyke DA; Stubbs WA J Physiol; 1983 Jul; 340():121-8. PubMed ID: 6887043 [TBL] [Abstract][Full Text] [Related]
25. Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in the rat. Vasko MR; Domino EF J Pharmacol Exp Ther; 1978 Dec; 207(3):848-58. PubMed ID: 731435 [TBL] [Abstract][Full Text] [Related]
26. The biochemical and behavioral effects of phospholipase A2 and morphine microinjections in the periaqueductal gray of the rat. Reichman M; Abood LG; Costanzo M Life Sci; 1985 Feb; 36(6):515-23. PubMed ID: 3968975 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions. Clausen TR; Møller M; Woldbye DP J Neurosci Res; 2001 May; 64(4):410-7. PubMed ID: 11340648 [TBL] [Abstract][Full Text] [Related]
28. Strain-dependent effects of morphine injected into the periaqueductal gray area of mice. Nunes-de-Souza RL; Graeff FG; Siegfried B Braz J Med Biol Res; 1991; 24(3):291-9. PubMed ID: 1823243 [TBL] [Abstract][Full Text] [Related]
29. Effects of cholecystokinin on morphine-elicited hyperactivity in hamsters. Schnur P; Cesar SS; Foderaro MA; Kulkosky PJ Pharmacol Biochem Behav; 1991 Jul; 39(3):581-6. PubMed ID: 1784587 [TBL] [Abstract][Full Text] [Related]
30. Modulation of intrathecal morphine-induced immunosuppression by microinjection of naloxone into periaqueductal gray. Zhang Y; Du LN; Wu GC; Cao XD Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):519-22. PubMed ID: 10437136 [TBL] [Abstract][Full Text] [Related]
31. [Analgesia induced by morphine administered to the nucleus accumbens was blocked by naloxone or [Met5] enkephalin antiserum injected into the periaqueductal gray of the rabbit]. Yu LC; Shi YS; Han JS Sheng Li Xue Bao; 1987 Aug; 39(4):326-33. PubMed ID: 3686052 [No Abstract] [Full Text] [Related]
32. Localization of the antinociceptive action of morphine in primate brain. Pert A; Yaksh T Pharmacol Biochem Behav; 1975; 3(1):133-8. PubMed ID: 1129350 [TBL] [Abstract][Full Text] [Related]
33. Evidence for sedative effects of low doses of morphine in mice involving receptors insensitive to naloxone. Marçais H; Bonnet JJ; Costentin J Life Sci; 1981 Jun; 28(24):2737-42. PubMed ID: 6267395 [No Abstract] [Full Text] [Related]
34. Analgesia and increases in limbic and cortical MOPEG-SO4 produced by periaqueductal gray injections of morphine. Reigle TG; Wilhoit CS; Moore MJ J Pharm Pharmacol; 1982 Aug; 34(8):496-500. PubMed ID: 6126559 [TBL] [Abstract][Full Text] [Related]
35. Cervicomedullary intrathecal injection of morphine produces antinociception in the orofacial formalin test in the rat. Grabow TS; Dougherty PM Anesthesiology; 2001 Dec; 95(6):1427-34. PubMed ID: 11748402 [TBL] [Abstract][Full Text] [Related]
36. Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone. Parolaro D; Sala M; Gori E Eur J Pharmacol; 1977 Dec; 46(4):329-38. PubMed ID: 590342 [TBL] [Abstract][Full Text] [Related]
37. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels. Buxbaum DM; Yarbrough GG; Carter ME J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383 [No Abstract] [Full Text] [Related]
38. The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections. Jacquet YF; Lajtha A Brain Res; 1976 Feb; 103(3):501-13. PubMed ID: 1252940 [TBL] [Abstract][Full Text] [Related]
39. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. Maldonado R; Stinus L; Gold LH; Koob GF J Pharmacol Exp Ther; 1992 May; 261(2):669-77. PubMed ID: 1578378 [TBL] [Abstract][Full Text] [Related]
40. Naloxone-precipitated jumping activity in mice following the acute administration of morphine. Kosersky DS; Harris RA; Harris LS Eur J Pharmacol; 1974 Apr; 26(1):122-4. PubMed ID: 4857602 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]